ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
McGrogan A, Madle GC, Seaman HE, de Vries CS, 2009. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 32: 150–163.
-
2.
Alter M, 1990. The epidemiology of Guillain-Barré syndrome. Ann Neurol 27 (Suppl): S7–S12.
-
3.
Govoni V, Granieri E, 2001. Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol 14: 605–613.
-
4.
Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meche FG, 2000. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54: 620–625.
-
5.
Hughes RA, Cornblath DR, 2005. Guillain-Barré syndrome. Lancet 366: 1653–1666.
-
6.
Hughes RA, Rees JH, 1997. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 176 (Suppl 2): S92–S98.
-
7.
Rees JH, Soudain SE, Gregson NA, Hughes RA, 1995. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333: 1374–1379.
-
8.
Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA, 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51: 1110–1115.
-
9.
Visser LH, van der Meche FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, van Doorn PA, 1996. Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 47: 668–673.
-
10.
Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Raphael JC, Durand MC, Sharshar T, Roussi J, Caudie C, Annane D, Rozenberg F, Leruez-Ville M, Gaillard JL, Gault E, 2011. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis 52: 837–844.
-
11.
Susuki K, Odaka M, Mori M, Hirata K, Yuki N, 2004. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 62: 949–956.
-
12.
Ratnam I, Leder K, Black J, Torresi J, 2013. Dengue fever and international travel. J Travel Med 20: 384–393.
-
13.
Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, Castro MJ, Faria LC, Peralta JM, 2009. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology 73: 1413–1417.
-
14.
Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, Haddad MB, Tierney BC, Slavinski SA, Polk JL, Dostrow V, Winkelmann M, Petersen LR, 2003. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 9: 788–793.
-
15.
Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ, 2000. Neurological manifestations of dengue infection. Lancet 355: 1053–1059.
-
16.
Van Koningsveld R, Rico R, Gerstenbluth I, Schmitz PI, Ang CW, Merkies IS, Jacobs BC, Halabi Y, Endtz HP, Van der Meche FG, Van Doorn PA, 2001. Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curacao. Neurology 56: 1467–1472.
-
17.
Asbury AK, Cornblath DR, 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (Suppl): S21–S24.
-
18.
Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, 2011. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29: 599–612.
-
19.
Vucic S, Kiernan MC, Cornblath DR, 2009. Guillain-Barré syndrome: an update. J Clin Neurosci 16: 733–741.
-
20.
Govoni V, Granieri E, Tola MR, Casetta I, Ruppi P, Vaghi L, 1999. The frequency of clinical variants of Guillain-Barre syndrome in Ferrara, Italy. J Neurol 246: 1010–1014.
-
21.
Arami MA, Yazdchi M, Khandaghi R, 2006. Epidemiology and characteristics of Guillain-Barré syndrome in the northwest of Iran. Ann Saudi Med 26: 22–27.
-
22.
Rocha MS, Brucki SM, Carvalho AA, Lima UW, 2004. Epidemiologic features of Guillain-Barré syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 62: 33–37.
-
23.
Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J, 1997. Epidemiological features of Guillain-Barré syndrome in Sweden, 1978–93. J Neurol Neurosurg Psychiatry 62: 447–453.
-
24.
Leslie T, Martin NJ, Jack-Roosberg C, Odongo G, Beausoleil E, Tuck J, Raviprakash K, Kochel TJ, 2014. Dengue serosurvey in Sint Eustatius. PLoS One 9: e95002.
-
25.
Soares CN, Faria LC, Peralta JM, de Freitas MR, Puccioni-Sohler M, 2006. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 249: 19–24.
-
26.
PAHO, 2003–2011. Number of Reported Cases of Dengue and Dengue Hemorrhagic Fever in the Americas, by Country. Washington, DC: PAHO.
-
27.
van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC, 2007. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol 6: 589–594.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 431 | 329 | 6 |
| Full Text Views | 440 | 6 | 0 |
| PDF Downloads | 148 | 10 | 0 |
Epidemiology of Guillain–Barré Syndrome in Aruba
Franciska S. T. Suryapranata
Franciska S. T. Suryapranata
Department of Medical Microbiology and Infection Control, VU University Medical Centre (VUMC), Amsterdam, The Netherlands; Department of Neurology, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Internal Medicine, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Microbiology, Landslaboratorium, Oranjestad, Aruba; Department of Virology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands; Institute of Tropical Medicine, Antwerp, Belgium
Search for other papers by Franciska S. T. Suryapranata in
Current site
Google Scholar
PubMed
Search for other papers by Franciska S. T. Suryapranata in
Current site
Google Scholar
PubMed
C. Wim Ang
C. Wim Ang
Department of Medical Microbiology and Infection Control, VU University Medical Centre (VUMC), Amsterdam, The Netherlands; Department of Neurology, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Internal Medicine, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Microbiology, Landslaboratorium, Oranjestad, Aruba; Department of Virology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands; Institute of Tropical Medicine, Antwerp, Belgium
Search for other papers by C. Wim Ang in
Current site
Google Scholar
PubMed
Search for other papers by C. Wim Ang in
Current site
Google Scholar
PubMed
Luis L. Chong
Luis L. Chong
Department of Medical Microbiology and Infection Control, VU University Medical Centre (VUMC), Amsterdam, The Netherlands; Department of Neurology, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Internal Medicine, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Microbiology, Landslaboratorium, Oranjestad, Aruba; Department of Virology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands; Institute of Tropical Medicine, Antwerp, Belgium
Search for other papers by Luis L. Chong in
Current site
Google Scholar
PubMed
Search for other papers by Luis L. Chong in
Current site
Google Scholar
PubMed
Jean-Luc Murk
Jean-Luc Murk
Department of Medical Microbiology and Infection Control, VU University Medical Centre (VUMC), Amsterdam, The Netherlands; Department of Neurology, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Internal Medicine, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Microbiology, Landslaboratorium, Oranjestad, Aruba; Department of Virology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands; Institute of Tropical Medicine, Antwerp, Belgium
Search for other papers by Jean-Luc Murk in
Current site
Google Scholar
PubMed
Search for other papers by Jean-Luc Murk in
Current site
Google Scholar
PubMed
Jaime Falconi
Jaime Falconi
Department of Medical Microbiology and Infection Control, VU University Medical Centre (VUMC), Amsterdam, The Netherlands; Department of Neurology, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Internal Medicine, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Microbiology, Landslaboratorium, Oranjestad, Aruba; Department of Virology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands; Institute of Tropical Medicine, Antwerp, Belgium
Search for other papers by Jaime Falconi in
Current site
Google Scholar
PubMed
Search for other papers by Jaime Falconi in
Current site
Google Scholar
PubMed
Ralph M. H. G. Huits
Ralph M. H. G. Huits
Department of Medical Microbiology and Infection Control, VU University Medical Centre (VUMC), Amsterdam, The Netherlands; Department of Neurology, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Internal Medicine, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba; Department of Microbiology, Landslaboratorium, Oranjestad, Aruba; Department of Virology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands; Institute of Tropical Medicine, Antwerp, Belgium
Search for other papers by Ralph M. H. G. Huits in
Current site
Google Scholar
PubMed
Search for other papers by Ralph M. H. G. Huits in
Current site
Google Scholar
PubMed
The epidemiology of Guillain–Barré syndrome (GBS) in tropical areas is different compared with developed countries. We investigated the epidemiology of GBS on the Caribbean island of Aruba. Data were collected retrospectively from all 36 patients hospitalized with GBS between 2003 and 2011 in Aruba. We observed a seasonal distribution of GBS cases with a peak in February. The incidence rate (IR) fluctuated heavily between individual years. The overall IR was 3.93/100,000, which is higher than that observed in developed countries. Serological studies indicated a possible relation of GBS cases with dengue virus infections. We also observed a relation between the annual number of dengue cases in Aruba and the number of GBS cases in the same year. We conclude that the epidemiology of GBS in tropical areas can be different from temperate climate regions and that dengue may be a trigger for developing GBS.
Author Notes
Authors' addresses: Franciska S. T. Suryapranata and C. Wim Ang, Department of Medical Microbiology and Infection Control, VU University Medical Centre (VUMC), Amsterdam, The Netherlands, E-mails: f.suryapranata@gmail.com and w.ang@vumc.nl. Luis L. Chong, Department of Microbiology, Landslaboratorium, Oranjestad, Aruba, E-mail: luis@landslab.org. Jean-Luc Murk, Department of Virology, University Medical Centre Utrecht (UMCU), Utrecht, The Netherlands, E-mail: j.murk@umcutrecht.nl. Jaime Falconi, Department of Neurology, Dr Horacio E. Oduber Hospital, Oranjestad, Aruba, E-mail: jrfalconi@hotmail.com. Ralph M. H. G. Huits, Institute of Tropical Medicine, Antwerp, Belgium, E-mail: ralph.huits@gmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
McGrogan A, Madle GC, Seaman HE, de Vries CS, 2009. The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 32: 150–163.
-
2.
Alter M, 1990. The epidemiology of Guillain-Barré syndrome. Ann Neurol 27 (Suppl): S7–S12.
-
3.
Govoni V, Granieri E, 2001. Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol 14: 605–613.
-
4.
Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meche FG, 2000. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology 54: 620–625.
-
5.
Hughes RA, Cornblath DR, 2005. Guillain-Barré syndrome. Lancet 366: 1653–1666.
-
6.
Hughes RA, Rees JH, 1997. Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 176 (Suppl 2): S92–S98.
-
7.
Rees JH, Soudain SE, Gregson NA, Hughes RA, 1995. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 333: 1374–1379.
-
8.
Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA, van Doorn PA, 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51: 1110–1115.
-
9.
Visser LH, van der Meche FG, Meulstee J, Rothbarth PP, Jacobs BC, Schmitz PI, van Doorn PA, 1996. Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 47: 668–673.
-
10.
Orlikowski D, Porcher R, Sivadon-Tardy V, Quincampoix JC, Raphael JC, Durand MC, Sharshar T, Roussi J, Caudie C, Annane D, Rozenberg F, Leruez-Ville M, Gaillard JL, Gault E, 2011. Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis 52: 837–844.
-
11.
Susuki K, Odaka M, Mori M, Hirata K, Yuki N, 2004. Acute motor axonal neuropathy after Mycoplasma infection: evidence of molecular mimicry. Neurology 62: 949–956.
-
12.
Ratnam I, Leder K, Black J, Torresi J, 2013. Dengue fever and international travel. J Travel Med 20: 384–393.
-
13.
Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, Castro MJ, Faria LC, Peralta JM, 2009. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology 73: 1413–1417.
-
14.
Sejvar JJ, Leis AA, Stokic DS, Van Gerpen JA, Marfin AA, Webb R, Haddad MB, Tierney BC, Slavinski SA, Polk JL, Dostrow V, Winkelmann M, Petersen LR, 2003. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 9: 788–793.
-
15.
Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, Loan HT, Day NP, Farrar J, Myint KS, Warrell MJ, James WS, Nisalak A, White NJ, 2000. Neurological manifestations of dengue infection. Lancet 355: 1053–1059.
-
16.
Van Koningsveld R, Rico R, Gerstenbluth I, Schmitz PI, Ang CW, Merkies IS, Jacobs BC, Halabi Y, Endtz HP, Van der Meche FG, Van Doorn PA, 2001. Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean island Curacao. Neurology 56: 1467–1472.
-
17.
Asbury AK, Cornblath DR, 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (Suppl): S21–S24.
-
18.
Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M, 2011. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29: 599–612.
-
19.
Vucic S, Kiernan MC, Cornblath DR, 2009. Guillain-Barré syndrome: an update. J Clin Neurosci 16: 733–741.
-
20.
Govoni V, Granieri E, Tola MR, Casetta I, Ruppi P, Vaghi L, 1999. The frequency of clinical variants of Guillain-Barre syndrome in Ferrara, Italy. J Neurol 246: 1010–1014.
-
21.
Arami MA, Yazdchi M, Khandaghi R, 2006. Epidemiology and characteristics of Guillain-Barré syndrome in the northwest of Iran. Ann Saudi Med 26: 22–27.
-
22.
Rocha MS, Brucki SM, Carvalho AA, Lima UW, 2004. Epidemiologic features of Guillain-Barré syndrome in Sao Paulo, Brazil. Arq Neuropsiquiatr 62: 33–37.
-
23.
Jiang GX, Cheng Q, Link H, de Pedro-Cuesta J, 1997. Epidemiological features of Guillain-Barré syndrome in Sweden, 1978–93. J Neurol Neurosurg Psychiatry 62: 447–453.
-
24.
Leslie T, Martin NJ, Jack-Roosberg C, Odongo G, Beausoleil E, Tuck J, Raviprakash K, Kochel TJ, 2014. Dengue serosurvey in Sint Eustatius. PLoS One 9: e95002.
-
25.
Soares CN, Faria LC, Peralta JM, de Freitas MR, Puccioni-Sohler M, 2006. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 249: 19–24.
-
26.
PAHO, 2003–2011. Number of Reported Cases of Dengue and Dengue Hemorrhagic Fever in the Americas, by Country. Washington, DC: PAHO.
-
27.
van Koningsveld R, Steyerberg EW, Hughes RA, Swan AV, van Doorn PA, Jacobs BC, 2007. A clinical prognostic scoring system for Guillain-Barré syndrome. Lancet Neurol 6: 589–594.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 431 | 329 | 6 |
| Full Text Views | 440 | 6 | 0 |
| PDF Downloads | 148 | 10 | 0 |